Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference is drawing significant interest across the industry.
PONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ('Treace” or the 'Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will highlight new product innovations and present new interim data for the ALIGN3D™, MTA3D™, and SpeedMTP® clinical studies at the American College of Foot and Ankle Surgeons ('ACFAS”) Annual Scientific Conference in Las Vegas, Nevada from February 24-26, 2026.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Vattenfall to combine wind and solar with new connection concept
- 'O'Romeo' box office collection Day 13: Shahid Kapoor and Triptii Dimri starrer goes BEYOND Rs 94 crore worldwide
- Canada Says It Could Have Bilateral Critical Sector Deals With US
- BRIT Awards 2026 winners revealed
Source: Original →